Amgen

AMGN · NASDAQ · USD

$403.04−1.04%−$4.23

Close · October 2, 2026

At a glance

Revenue growth: +9.95%; 2025 vs 2024
Net income growth: +88.53%; 2025 vs 2024
Net margin: 21.0%; 2024: 12.2%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
Item	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Total revenue	10,054	8,618	9,866	9,557	9,179	8,149	9,086	8,503	8,388	7,447	8,196	6,903
Cost of revenue	2,751	2,497	2,676	2,744	2,672	2,605	2,712	2,649	2,576	2,507	2,456	1,806
Gross profit	7,303	6,121	7,190	6,813	6,507	5,544	6,374	5,854	5,812	4,940	5,740	5,097
Selling, general and administrative	1,745	1,602	1,952	1,720	1,691	1,687	1,878	1,625	1,785	1,808	1,787	1,353
Research and development	1,868	1,719	2,142	1,900	1,744	1,486	1,724	1,450	1,447	1,343	1,534	1,079
Operating income	3,574	2,913	3,014	3,264	2,995	2,341	2,600	2,708	2,569	1,752	3,197	1,874
EBIT	3,574	2,913	3,014	3,264	2,995	2,341	2,600	2,708	2,569	1,752	3,197	1,874
EBITDA	4,686	4,029	4,022	4,571	4,336	3,728	3,886	4,104	3,969	3,151	4,438	2,769
Interest expense	673	657	1,061	685	694	723	1,257	776	808	824	2,046	759
Pre-tax income	2,768	2,084	1,514	3,921	1,568	1,973	782	3,101	794	-68.0	852	1,947
Income tax	393	265	181	705	136	243	155	271	48.0	45.0	85.0	217
Net income	2,375	1,819	1,333	3,216	1,432	1,730	627	2,830	746	-113	767	1,730
Net income to common shareholders	2,375	1,819	1,333	3,216	1,432	1,730	627	2,830	746	-113	767	1,730
Basic EPS	4.40	3.37	2.47	5.98	2.66	3.22	1.17	5.27	1.39	-0.21	1.43	3.23
Diluted EPS	4.37	3.34	2.46	5.93	2.65	3.20	1.16	5.22	1.38	-0.21	1.42	3.22
Average shares (basic)	540	540	539	538	538	538	537	537	537	536	535	535
Average shares (diluted)	544	544	543	542	541	541	542	542	541	536	540	538
Dividend per share	2.52	2.52	2.38	2.38	2.38	2.38	2.25	2.25	2.25	2.25	2.13	2.13